HIV drug shows efficacy in treating mouse models of HER2+ breast cancer, study suggests
Friday, October 5, 2012 - 16:30
in Health & Medicine
The HIV protease inhibitor, Nelfinavir, can be used to treat HER2-positive breast cancer in the same capacity and dosage regimen that it is used to treat HIV, according to a new study.